25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Applied DNA Sciences Inc
Buy, Hold or Sell?

Let's analyze Applied DNA Sciences Inc together

I guess you are interested in Applied DNA Sciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Applied DNA Sciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Applied DNA Sciences Inc

I send you an email if I find something interesting about Applied DNA Sciences Inc.

1. Quick Overview

1.1. Quick analysis of Applied DNA Sciences Inc (30 sec.)










1.2. What can you expect buying and holding a share of Applied DNA Sciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.01
When do you have the money?
1 year
How often do you get paid?
15.0%

What is your share worth?

Current worth
$1.19
Expected worth in 1 year
$1.68
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$0.50
Return On Investment
260.3%

For what price can you sell your share?

Current Price per Share
$0.19
Expected price per share
$0.172 - $0.4266
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Applied DNA Sciences Inc (5 min.)




Live pricePrice per Share (EOD)
$0.19
Intrinsic Value Per Share
$-15.74 - $-10.40
Total Value Per Share
$-14.55 - $-9.21

2.2. Growth of Applied DNA Sciences Inc (5 min.)




Is Applied DNA Sciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$12.2m$9.8m-$4.5m-86.3%

How much money is Applied DNA Sciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1.8m-$1.7m-$59.4k-3.2%
Net Profit Margin-209.7%-46.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Applied DNA Sciences Inc (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#97 / 136

Most Revenue
#119 / 136

Most Profit
#75 / 136

Most Efficient
#114 / 136
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Applied DNA Sciences Inc?

Welcome investor! Applied DNA Sciences Inc's management wants to use your money to grow the business. In return you get a share of Applied DNA Sciences Inc.

First you should know what it really means to hold a share of Applied DNA Sciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Applied DNA Sciences Inc is $0.1909. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Applied DNA Sciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Applied DNA Sciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.19. Based on the TTM, the Book Value Change Per Share is $0.12 per quarter. Based on the YOY, the Book Value Change Per Share is $0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Applied DNA Sciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.1895.6%-0.18-93.7%-0.26-136.1%-0.27-138.9%-0.27-143.4%
Usd Book Value Change Per Share1.20631.2%0.1264.1%0.015.1%0.0735.7%0.0315.2%
Usd Dividend Per Share0.000.0%0.001.0%0.000.0%0.000.8%0.000.4%
Usd Total Gains Per Share1.20631.2%0.1265.1%0.015.1%0.0736.4%0.0315.6%
Usd Price Per Share0.41-0.66-1.30-3.17-2.64-
Price to Earnings Ratio0.56--0.47--1.88--2.92--2.98-
Price-to-Total Gains Ratio0.34--3.89-1.73-205.10-128.81-
Price to Book Ratio0.34--4.91-1.45-2.50-3.01-
Price-to-Total Gains Ratio0.34--3.89-1.73-205.10-128.81-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.1909
Number of shares5238
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.120.07
Usd Total Gains Per Share0.120.07
Gains per Quarter (5238 shares)650.74364.38
Gains per Year (5238 shares)2,602.951,457.52
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
140256325933114261448
279512751966228532906
3119769077999442794364
4158102541040212557055822
5198128171300515671327280
6237153801560818785588738
72771794418211218998410196
831620507208142491141111654
935623071234172811283713112
1039525634260203121426314570

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%1.011.00.08.3%1.019.00.05.0%1.039.00.02.5%4.083.00.04.6%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%9.011.00.045.0%16.024.00.040.0%32.050.05.036.8%
Dividend per Share1.00.03.025.0%3.00.09.025.0%6.00.014.030.0%6.00.034.015.0%6.00.081.06.9%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%9.011.00.045.0%16.024.00.040.0%32.050.05.036.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Applied DNA Sciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.2050.122+885%0.010+12329%0.068+1670%0.029+4063%
Book Value Per Share--1.1880.511+132%0.952+25%0.788+51%0.726+64%
Current Ratio--3.9142.552+53%4.678-16%3.970-1%3.635+8%
Debt To Asset Ratio--0.2670.628-58%0.498-46%0.464-42%0.477-44%
Debt To Equity Ratio--0.3600.875-59%1.011-64%0.666-46%0.816-56%
Dividend Per Share---0.002-100%-0%0.001-100%0.001-100%
Eps--0.183-0.179+198%-0.260+242%-0.265+245%-0.274+250%
Free Cash Flow Per Share---0.341-0.317-7%-0.176-49%-0.273-20%-0.235-31%
Free Cash Flow To Equity Per Share--0.7080.041+1636%0.165+329%0.063+1023%0.121+487%
Gross Profit Margin--1.0001.0000%1.0000%1.013-1%1.007-1%
Intrinsic Value_10Y_max---10.396--------
Intrinsic Value_10Y_min---15.739--------
Intrinsic Value_1Y_max---0.955--------
Intrinsic Value_1Y_min---1.132--------
Intrinsic Value_3Y_max---2.935--------
Intrinsic Value_3Y_min---3.806--------
Intrinsic Value_5Y_max---4.995--------
Intrinsic Value_5Y_min---6.905--------
Market Cap1966155.460-114%4206274.9606810993.220-38%13414968.500-69%32678399.793-87%27223992.044-85%
Net Profit Margin--2.357-2.097+189%-0.469+120%-2.496+206%-2.729+216%
Operating Margin---4.196-5.329+27%-0.614-85%-3.168-24%-2.958-30%
Operating Ratio--5.1965.422-4%1.763+195%3.955+31%4.498+16%
Pb Ratio0.161-114%0.344-4.909+1528%1.446-76%2.504-86%3.012-89%
Pe Ratio0.261-114%0.559-0.472+184%-1.877+436%-2.919+622%-2.984+633%
Price Per Share0.191-114%0.4080.661-38%1.303-69%3.173-87%2.643-85%
Price To Free Cash Flow Ratio-0.140+53%-0.299-0.566+89%3.342-109%-2.490+733%-2.697+802%
Price To Total Gains Ratio0.158-114%0.339-3.886+1247%1.732-80%205.096-100%128.807-100%
Quick Ratio--3.6212.263+60%4.327-16%3.561+2%3.317+9%
Return On Assets--0.113-0.189+268%-0.097+187%-0.213+289%-0.306+371%
Return On Equity--0.152-0.213+241%-0.212+240%-0.300+298%-0.560+469%
Total Gains Per Share--1.2050.124+870%0.010+12329%0.070+1632%0.030+3959%
Usd Book Value--12234454.0005264970.750+132%9807417.250+25%8114753.550+51%7474355.600+64%
Usd Book Value Change Per Share--1.2050.122+885%0.010+12329%0.068+1670%0.029+4063%
Usd Book Value Per Share--1.1880.511+132%0.952+25%0.788+51%0.726+64%
Usd Dividend Per Share---0.002-100%-0%0.001-100%0.001-100%
Usd Eps--0.183-0.179+198%-0.260+242%-0.265+245%-0.274+250%
Usd Free Cash Flow---3516486.000-3265420.000-7%-1808678.000-49%-2807192.300-20%-2416232.875-31%
Usd Free Cash Flow Per Share---0.341-0.317-7%-0.176-49%-0.273-20%-0.235-31%
Usd Free Cash Flow To Equity Per Share--0.7080.041+1636%0.165+329%0.063+1023%0.121+487%
Usd Market Cap1966155.460-114%4206274.9606810993.220-38%13414968.500-69%32678399.793-87%27223992.044-85%
Usd Price Per Share0.191-114%0.4080.661-38%1.303-69%3.173-87%2.643-85%
Usd Profit--1879796.000-1841449.750+198%-1781965.500+195%-2500244.400+233%-2702880.250+244%
Usd Revenue--797519.000849512.500-6%4036756.000-80%2339325.550-66%1824945.325-56%
Usd Total Gains Per Share--1.2050.124+870%0.010+12329%0.070+1632%0.030+3959%
 EOD+3 -5MRQTTM+23 -12YOY+20 -135Y+20 -1610Y+21 -15

3.3 Fundamental Score

Let's check the fundamental score of Applied DNA Sciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-150.261
Price to Book Ratio (EOD)Between0-10.161
Net Profit Margin (MRQ)Greater than02.357
Operating Margin (MRQ)Greater than0-4.196
Quick Ratio (MRQ)Greater than13.621
Current Ratio (MRQ)Greater than13.914
Debt to Asset Ratio (MRQ)Less than10.267
Debt to Equity Ratio (MRQ)Less than10.360
Return on Equity (MRQ)Greater than0.150.152
Return on Assets (MRQ)Greater than0.050.113
Total9/10 (90.0%)

3.4 Technical Score

Let's check the technical score of Applied DNA Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.030
Ma 20Greater thanMa 500.268
Ma 50Greater thanMa 1000.703
Ma 100Greater thanMa 2000.716
OpenGreater thanClose0.190
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Applied DNA Sciences Inc

Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

Fundamental data was last updated by Penke on 2024-10-24 07:28:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Applied DNA Sciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Applied DNA Sciences Inc to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 235.7% means that $2.36 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Applied DNA Sciences Inc:

  • The MRQ is 235.7%. The company is making a huge profit. +2
  • The TTM is -209.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ235.7%TTM-209.7%+445.4%
TTM-209.7%YOY-46.9%-162.7%
TTM-209.7%5Y-249.6%+40.0%
5Y-249.6%10Y-272.9%+23.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ235.7%-2.6%+238.3%
TTM-209.7%-7.1%-202.6%
YOY-46.9%-5.1%-41.8%
5Y-249.6%-2.7%-246.9%
10Y-272.9%-0.3%-272.6%
4.3.1.2. Return on Assets

Shows how efficient Applied DNA Sciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Applied DNA Sciences Inc to the Diagnostics & Research industry mean.
  • 11.3% Return on Assets means that Applied DNA Sciences Inc generated $0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Applied DNA Sciences Inc:

  • The MRQ is 11.3%. Using its assets, the company is efficient in making profit. +1
  • The TTM is -18.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ11.3%TTM-18.9%+30.2%
TTM-18.9%YOY-9.7%-9.2%
TTM-18.9%5Y-21.3%+2.4%
5Y-21.3%10Y-30.6%+9.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ11.3%-1.2%+12.5%
TTM-18.9%-1.3%-17.6%
YOY-9.7%-1.0%-8.7%
5Y-21.3%-0.3%-21.0%
10Y-30.6%-0.5%-30.1%
4.3.1.3. Return on Equity

Shows how efficient Applied DNA Sciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Applied DNA Sciences Inc to the Diagnostics & Research industry mean.
  • 15.2% Return on Equity means Applied DNA Sciences Inc generated $0.15 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Applied DNA Sciences Inc:

  • The MRQ is 15.2%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is -21.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ15.2%TTM-21.3%+36.5%
TTM-21.3%YOY-21.2%-0.1%
TTM-21.3%5Y-30.0%+8.6%
5Y-30.0%10Y-56.0%+26.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ15.2%-0.5%+15.7%
TTM-21.3%-0.7%-20.6%
YOY-21.2%-0.2%-21.0%
5Y-30.0%-1.0%-29.0%
10Y-56.0%-1.0%-55.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Applied DNA Sciences Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Applied DNA Sciences Inc is operating .

  • Measures how much profit Applied DNA Sciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Applied DNA Sciences Inc to the Diagnostics & Research industry mean.
  • An Operating Margin of -419.6% means the company generated $-4.20  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Applied DNA Sciences Inc:

  • The MRQ is -419.6%. The company is operating very inefficient. -2
  • The TTM is -532.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-419.6%TTM-532.9%+113.3%
TTM-532.9%YOY-61.4%-471.5%
TTM-532.9%5Y-316.8%-216.1%
5Y-316.8%10Y-295.8%-21.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-419.6%-16.8%-402.8%
TTM-532.9%-14.1%-518.8%
YOY-61.4%1.8%-63.2%
5Y-316.8%2.0%-318.8%
10Y-295.8%5.0%-300.8%
4.3.2.2. Operating Ratio

Measures how efficient Applied DNA Sciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 5.20 means that the operating costs are $5.20 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Applied DNA Sciences Inc:

  • The MRQ is 5.196. The company is inefficient in keeping operating costs low. -1
  • The TTM is 5.422. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ5.196TTM5.422-0.226
TTM5.422YOY1.763+3.659
TTM5.4225Y3.955+1.467
5Y3.95510Y4.498-0.542
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ5.1961.314+3.882
TTM5.4221.283+4.139
YOY1.7631.268+0.495
5Y3.9551.239+2.716
10Y4.4981.192+3.306
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Applied DNA Sciences Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Applied DNA Sciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 3.91 means the company has $3.91 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Applied DNA Sciences Inc:

  • The MRQ is 3.914. The company is very able to pay all its short-term debts. +2
  • The TTM is 2.552. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ3.914TTM2.552+1.362
TTM2.552YOY4.678-2.126
TTM2.5525Y3.970-1.418
5Y3.97010Y3.635+0.336
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.9142.015+1.899
TTM2.5522.134+0.418
YOY4.6782.558+2.120
5Y3.9702.748+1.222
10Y3.6353.230+0.405
4.4.3.2. Quick Ratio

Measures if Applied DNA Sciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Applied DNA Sciences Inc to the Diagnostics & Research industry mean.
  • A Quick Ratio of 3.62 means the company can pay off $3.62 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Applied DNA Sciences Inc:

  • The MRQ is 3.621. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.263. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.621TTM2.263+1.358
TTM2.263YOY4.327-2.064
TTM2.2635Y3.561-1.298
5Y3.56110Y3.317+0.244
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6211.195+2.426
TTM2.2631.275+0.988
YOY4.3271.694+2.633
5Y3.5612.141+1.420
10Y3.3172.443+0.874
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Applied DNA Sciences Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Applied DNA Sciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Applied DNA Sciences Inc to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.27 means that Applied DNA Sciences Inc assets are financed with 26.7% credit (debt) and the remaining percentage (100% - 26.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Applied DNA Sciences Inc:

  • The MRQ is 0.267. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.628. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.267TTM0.628-0.361
TTM0.628YOY0.498+0.130
TTM0.6285Y0.464+0.164
5Y0.46410Y0.477-0.012
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2670.440-0.173
TTM0.6280.438+0.190
YOY0.4980.359+0.139
5Y0.4640.417+0.047
10Y0.4770.443+0.034
4.5.4.2. Debt to Equity Ratio

Measures if Applied DNA Sciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Applied DNA Sciences Inc to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 36.0% means that company has $0.36 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Applied DNA Sciences Inc:

  • The MRQ is 0.360. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.875. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.360TTM0.875-0.515
TTM0.875YOY1.011-0.137
TTM0.8755Y0.666+0.209
5Y0.66610Y0.816-0.150
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3600.642-0.282
TTM0.8750.669+0.206
YOY1.0110.517+0.494
5Y0.6660.661+0.005
10Y0.8160.730+0.086
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Applied DNA Sciences Inc generates.

  • Above 15 is considered overpriced but always compare Applied DNA Sciences Inc to the Diagnostics & Research industry mean.
  • A PE ratio of 0.56 means the investor is paying $0.56 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Applied DNA Sciences Inc:

  • The EOD is 0.261. Based on the earnings, the company is cheap. +2
  • The MRQ is 0.559. Based on the earnings, the company is cheap. +2
  • The TTM is -0.472. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.261MRQ0.559-0.298
MRQ0.559TTM-0.472+1.031
TTM-0.472YOY-1.877+1.406
TTM-0.4725Y-2.919+2.447
5Y-2.91910Y-2.984+0.064
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD0.261-0.398+0.659
MRQ0.559-0.799+1.358
TTM-0.472-0.715+0.243
YOY-1.877-0.093-1.784
5Y-2.9192.123-5.042
10Y-2.9843.433-6.417
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Applied DNA Sciences Inc:

  • The EOD is -0.140. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.299. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.566. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.140MRQ-0.299+0.159
MRQ-0.299TTM-0.566+0.267
TTM-0.566YOY3.342-3.909
TTM-0.5665Y-2.490+1.924
5Y-2.49010Y-2.697+0.207
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.140-0.822+0.682
MRQ-0.299-1.106+0.807
TTM-0.566-1.237+0.671
YOY3.342-2.800+6.142
5Y-2.490-2.255-0.235
10Y-2.697-2.805+0.108
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Applied DNA Sciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 0.34 means the investor is paying $0.34 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Applied DNA Sciences Inc:

  • The EOD is 0.161. Based on the equity, the company is cheap. +2
  • The MRQ is 0.344. Based on the equity, the company is cheap. +2
  • The TTM is -4.909. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.161MRQ0.344-0.183
MRQ0.344TTM-4.909+5.253
TTM-4.909YOY1.446-6.355
TTM-4.9095Y2.504-7.414
5Y2.50410Y3.012-0.508
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD0.1612.252-2.091
MRQ0.3442.071-1.727
TTM-4.9092.192-7.101
YOY1.4462.268-0.822
5Y2.5043.746-1.242
10Y3.0124.266-1.254
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Applied DNA Sciences Inc.

4.8.1. Institutions holding Applied DNA Sciences Inc

Institutions are holding 11.859% of the shares of Applied DNA Sciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-06-30AMH Equity Ltd6.30920.35186498096498090
2024-06-30Altium Capital Management, LP0.83650.014486152861520
2024-06-30Sabby Management LLC0.68410.019470463704630
2024-06-30Virtu Financial LLC0.18470.000619021190210
2024-06-30Ground Swell Capital, LLC0.14810.004815250152500
2024-06-30XTX Topco Ltd0.09960.000410261102610
2024-06-30BlackRock Inc0.04920506650660
2024-06-30Tower Research Capital LLC0.03950406940690
2024-06-30Morgan Stanley - Brokerage Accounts0.03860397539750
2024-06-30Nordwand Advisors LLC0.00970.0002100010000
2024-06-30Natixis SA0.006606776770
2024-06-30Wells Fargo & Co0.001401411410
2024-06-30Activest Wealth Management0.00101011010
2024-06-30Royal Bank of Canada0.0008085850
2024-06-30UBS Group AG0.0007076760
2024-06-30Bank of America Corp0.0003030300
2024-06-30FMR Inc0.0002025250
2024-06-30Advisor Group Holdings, Inc.00220
2024-09-30Dakota Community Bank & Trust NA00220
2024-03-31Susquehanna International Group, LLP000-72354-100
Total 8.41020.3916866205+793851+91.6%

4.9.2. Funds holding Applied DNA Sciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31SSgA U.S. Extended Market Index Class I0.00450.0002931700
2024-08-31Vanguard Institutional Extnd Mkt Idx Tr0.08420867700
2024-08-31Fidelity Extended Market Index0.03530363400
2024-09-30BlackRock Extended Equity Market K0.018101867-1-0.0535
2024-08-31Fidelity Total Market Index0.01460150400
2024-08-31Fidelity Series Total Market Index0.0085087500
2024-08-31Fidelity Nasdaq Composite Index0.0075077000
2023-12-31NT US Market Cap Idx Fd - L0.0003059500
2024-06-30Northern Trust Extended Eq Market Idx0.0057058910.1701
2024-09-30NT Ext Equity Mkt Idx Fd - L0.0057058900
2024-09-30State St US Extended Mkt Indx NL Cl C0.0045046600
2024-09-30Extended Equity Market Fund M0.00230237-1-0.4202
2024-06-30SSgA U.S. Total Market Index Strategy0.001901915742.5373
2024-09-30NT Ext Equity Mkt Idx Fd - NL0.0017017200
2024-09-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.0013013900
2024-09-30Vanguard U.S. Eq Idx £ Acc0.0012012100
2024-09-30NT Ext Eq Mkt Indx Fd DC Lending Tier 50.000909100
2024-06-30Northern Trust Wilshire 50000.000303000
2024-08-31Fidelity U.S. Equity Index Ins Trust0.00010700
Total 0.19860.000229871+56+0.2%

5.3. Insider Transactions

Insiders are holding 3.044% of the shares of Applied DNA Sciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2020-06-26William W MontgomeryBUY1100005.25135000
2020-06-18William W MontgomeryBUY400005.25215000
2020-06-09William W MontgomeryBUY750005.25140000
2019-11-13William W. MontgomeryBUY750005.24
2019-09-16William W MontgomeryBUY66780.366024222
2019-08-22William W MontgomeryBUY4000000.275630900
2019-01-24William W MontgomeryBUY500000.475180900
2019-01-22William W MontgomeryBUY600000.445030900
2019-01-18William W MontgomeryBUY1000000.445030900
2019-01-07William W MontgomeryBUY4000000.454560900
2019-01-03William W MontgomeryBUY1540000.444560900
2018-12-31William W MontgomeryBUY300000.374560900
2014-11-20James A HaywardBUY769233.24
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Income before Tax  -3,114-501-3,6162,485-1,130-3,364-4,4946,3431,850
Net Income  -3,100-492-3,5922,409-1,183-3,288-4,4706,3501,880
Net Income from Continuing Operations  -3,114-501-3,6162,485-1,130-3,364-4,4946,3431,850



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets16,690
Total Liabilities4,456
Total Stockholder Equity12,392
 As reported
Total Liabilities 4,456
Total Stockholder Equity+ 12,392
Total Assets = 16,690

Assets

Total Assets16,690
Total Current Assets11,842
Long-term Assets4,848
Total Current Assets
Cash And Cash Equivalents 10,442
Net Receivables 514
Inventory 470
Other Current Assets 416
Total Current Assets  (as reported)11,842
Total Current Assets  (calculated)11,842
+/- 0
Long-term Assets
Property Plant Equipment 1,399
Intangible Assets 2,699
Long-term Assets Other 750
Long-term Assets  (as reported)4,848
Long-term Assets  (calculated)4,848
+/- 0

Liabilities & Shareholders' Equity

Total Current Liabilities3,026
Long-term Liabilities1,430
Total Stockholder Equity12,392
Total Current Liabilities
Short-term Debt 534
Accounts payable 1,599
Other Current Liabilities 842
Total Current Liabilities  (as reported)3,026
Total Current Liabilities  (calculated)2,974
+/- 51
Long-term Liabilities
Capital Lease Obligations 868
Long-term Liabilities  (as reported)1,430
Long-term Liabilities  (calculated)868
+/- 562
Total Stockholder Equity
Common Stock10
Retained Earnings -306,376
Other Stockholders Equity 318,758
Total Stockholder Equity (as reported)12,392
Total Stockholder Equity (calculated)12,392
+/-0
Other
Capital Stock10
Cash and Short Term Investments 10,442
Common Stock Shares Outstanding 4,014
Current Deferred Revenue51
Liabilities and Stockholders Equity 16,690
Net Debt -9,574
Net Invested Capital 12,392
Net Working Capital 8,817
Property Plant and Equipment Gross 1,399
Short Long Term Debt Total 868



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-31
> Total Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34
98
207
895
277
85
82
82
3,071
1,295
9,183
9,183
8,586
11,694
4,677
4,677
2,460
2,203
2,412
2,412
2,563
2,563
1,847
1,533
1,799
1,550
1,507
1,133
1,070
1,020
1,413
1,774
1,238
894
3,504
2,522
1,452
1,970
1,349
1,625
5,073
3,841
8,375
6,241
3,782
3,771
3,506
5,022
3,627
14,123
15,554
20,485
17,712
15,219
15,566
16,770
13,217
10,423
8,154
9,609
7,934
6,608
5,634
6,149
4,226
2,985
3,565
10,872
11,327
13,975
11,341
9,678
20,782
17,190
14,417
11,402
13,879
11,920
22,265
20,297
19,175
15,790
13,652
9,913
9,176
16,690
16,6909,1769,91313,65215,79019,17520,29722,26511,92013,87911,40214,41717,19020,7829,67811,34113,97511,32710,8723,5652,9854,2266,1495,6346,6087,9349,6098,15410,42313,21716,77015,56615,21917,71220,48515,55414,1233,6275,0223,5063,7713,7826,2418,3753,8415,0731,6251,3491,9701,4522,5223,5048941,2381,7741,4131,0201,0701,1331,5071,5501,7991,5331,8472,5632,5632,4122,4122,2032,4604,6774,67711,6948,5869,1839,1831,2953,07182828527789520798340000000000000000
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26
79
193
624
198
0
2
2
2,975
1,192
44
44
81
2,108
1,350
1,350
116
174
526
526
789
789
295
174
564
357
340
74
160
181
242
638
274
293
3,032
2,218
1,204
1,807
1,102
1,399
4,839
2,561
7,207
5,075
2,702
2,715
2,363
4,135
2,300
13,018
11,535
16,494
14,939
12,143
11,352
13,314
9,749
8,144
6,241
7,774
6,104
4,828
4,002
4,600
2,763
1,605
2,146
9,638
9,979
12,155
9,078
6,540
17,419
13,696
11,298
8,499
11,156
9,268
19,943
18,332
15,380
12,240
8,127
4,590
4,365
11,842
11,8424,3654,5908,12712,24015,38018,33219,9439,26811,1568,49911,29813,69617,4196,5409,07812,1559,9799,6382,1461,6052,7634,6004,0024,8286,1047,7746,2418,1449,74913,31411,35212,14314,93916,49411,53513,0182,3004,1352,3632,7152,7025,0757,2072,5614,8391,3991,1021,8071,2042,2183,032293274638242181160743403575641742957897895265261741161,3501,3502,1088144441,1922,97522019862419379260000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26
79
193
624
198
0
2
2
2,975
1,192
31
31
78
1,931
1,225
1,225
89
35
25
25
585
585
136
51
14
17
213
6
99
22
18
468
123
12
2,747
1,936
857
1,256
725
984
4,406
1,832
6,360
4,199
1,988
2,026
1,393
2,872
984
10,730
7,312
12,383
9,786
7,087
4,479
6,702
4,020
2,403
2,960
4,765
3,709
2,515
1,660
3,138
1,541
507
559
8,663
8,663
10,925
7,787
4,241
13,926
12,173
6,555
2,748
6,513
4,682
15,215
12,877
12,287
10,756
7,152
3,359
3,150
10,442
10,4423,1503,3597,15210,75612,28712,87715,2154,6826,5132,7486,55512,17313,9264,2417,78710,9258,6638,6635595071,5413,1381,6602,5153,7094,7652,9602,4034,0206,7024,4797,0879,78612,3837,31210,7309842,8721,3932,0261,9884,1996,3601,8324,4069847251,2568571,9362,747121234681822996213171451136585585252535891,2251,2251,9317831311,1922,97522019862419379260000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
12
3
31
18
18
0
0
0
14
89
89
75
71
64
16
47
16
36
57
63
63
99
178
209
233
324
443
297
362
408
588
673
749
606
518
835
1,115
1,160
2,078
3,930
3,924
5,027
4,792
6,375
6,156
5,192
5,251
2,588
2,156
1,526
1,415
1,486
615
316
244
840
274
549
231
194
1,034
2,186
737
2,804
3,857
2,588
2,859
3,068
4,053
1,968
683
256
451
409
514
5144094512566831,9684,0533,0682,8592,5883,8572,8047372,1861,0341942315492748402443166151,4861,4151,5262,1562,5885,2515,1926,1566,3754,7925,0273,9243,9302,0781,1601,11583551860674967358840836229744332423320917899636357361647166471758989140001818313121200000000000000000000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
147
107
107
27
139
0
501
115
115
83
52
486
323
79
52
25
103
161
106
52
103
76
50
24
108
80
52
25
142
174
126
108
171
135
149
156
210
293
187
126
137
200
133
183
113
367
540
575
603
635
622
591
545
605
618
678
555
599
721
586
356
569
593
644
555
1,058
925
759
525
389
403
470
416
4164704033895257599251,05855564459356935658672159955567861860554559162263560357554036711318313320013712618729321015614913517110812617414225528010824507610352106161103255279323486528311511550101392710710714700000000000000000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
19
14
271
79
85
80
80
96
102
9,139
9,139
8,505
9,585
3,327
3,327
2,344
2,030
0
1,886
1,774
1,774
1,552
1,359
1,234
1,193
1,167
1,059
911
838
1,171
1,137
964
601
471
303
248
164
247
226
234
1,280
1,168
1,165
1,080
1,056
1,143
887
1,327
1,106
4,019
3,990
2,773
3,076
4,214
3,455
3,468
2,279
1,913
1,835
1,829
1,780
1,632
1,549
1,463
1,380
1,418
1,234
1,348
1,820
2,263
3,138
3,362
3,493
3,119
2,903
2,724
2,652
2,322
1,965
3,796
3,549
5,525
5,323
4,811
4,848
4,8484,8115,3235,5253,5493,7961,9652,3222,6522,7242,9033,1193,4933,3623,1382,2631,8201,3481,2341,4181,3801,4631,5491,6321,7801,8291,8351,9132,2793,4683,4554,2143,0762,7733,9904,0191,1061,3278871,1431,0561,0801,1651,1681,2802342262471642483034716019641,1371,1718389111,0591,1671,1931,2341,3591,5521,7741,7741,88602,0302,3443,3273,3279,5858,5059,1399,1391029680808579271141980000000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
29
29
28
28
28
22
21
8
8
42
38
156
156
137
121
106
106
81
81
64
47
33
19
12
9
8
6
4
2
1
0
89
82
121
127
211
190
198
664
696
717
647
649
576
521
588
527
572
562
879
806
792
724
672
590
524
500
551
536
420
369
316
265
226
184
265
751
1,278
2,175
2,423
2,577
3,024
2,808
2,629
2,557
2,223
1,866
3,046
2,524
2,076
1,657
1,362
1,399
1,3991,3621,6572,0762,5243,0461,8662,2232,5572,6292,8083,0242,5772,4232,1751,2787512651842262653163694205365515005245906727247928068795625725275885215766496477176966641981902111271218289012468912193347648181106106121137156156384288212228282829290000000000000000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
14
18
27
33
28
28
26
25
9,117
8,778
8,440
8,101
2,107
2,015
1,922
1,829
1,737
1,644
1,459
1,459
1,367
1,275
1,183
1,092
1,001
909
819
728
637
546
0
364
273
182
91
0
0
0
0
565
421
397
375
351
328
304
389
526
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
0
0
0
0
0
0
0
0
0
0
0
0
00000000000028528528528528528528528528528528528528528528528528528528528528528528528552638930432835137539742156500009118227336405466377288199091,0011,0921,1831,2751,3671,4591,4591,6441,7371,8291,9222,0152,1078,1018,4408,7789,1172526282833271814400000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,500
1,500
0
360
1,535
920
1,045
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000001,0459201,53536001,5001,500000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
14
18
27
33
28
28
26
25
9,117
9,117
8,440
8,101
2,107
2,107
1,922
1,829
1,737
1,737
1,459
1,459
1,367
1,275
1,183
1,092
1,001
909
819
728
637
546
0
364
273
182
91
0
0
0
0
565
421
397
375
351
328
304
389
526
1,599
1,584
1,549
1,564
1,526
1,465
1,404
1,343
1,042
986
930
897
864
832
799
767
735
702
721
689
605
582
559
536
0
0
0
0
0
0
0
0
2,699
2,699
2,699
2,699
2,6992,6992,6992,699000000005365595826056897217027357677998328648979309861,0421,3431,4041,4651,5261,5641,5491,5841,59952638930432835137539742156500009118227336405466377288199091,0011,0921,1831,2751,3671,4591,4591,7371,7371,8291,9222,1072,1078,1018,4409,1179,1172526282833271814400000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
222
127
36
36
36
36
616
472
449
433
407
567
366
739
579
3,447
3,429
1,894
2,270
3,422
2,732
2,796
1,689
1,389
1,334
62
62
62
62
62
62
172
62
76
95
95
95
95
95
95
95
95
95
99
99
0
1,026
0
0
0
0
00001,0260999995959595959595959576621726262626262621,3341,3891,6892,7962,7323,4222,2701,8943,4293,44757973936656740743344947261636363636127222000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
288
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
110
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000110000000000000000002880000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
1
1
1
1
1
1
1
0
0
0
0
0
119
178
349
785
895
1,406
2,121
4,788
4,788
2,292
1,545
2,596
2,596
10,252
14,096
14,263
14,263
21,677
15,191
14,356
14,356
16,007
16,007
15,884
13,863
1,995
2,470
3,254
4,017
4,197
3,536
3,011
3,578
3,362
4,868
4,499
3,876
638
654
592
8,323
8,844
1,533
3,759
4,358
4,103
3,460
4,975
1,721
1,671
1,623
2,987
2,489
2,684
3,033
5,200
4,588
3,926
2,405
1,296
1,470
2,226
3,550
4,879
5,383
4,960
4,774
4,413
3,648
4,058
5,196
5,632
3,955
2,162
1,606
3,304
3,010
6,233
5,126
9,356
11,139
9,207
8,595
8,779
5,785
9,351
4,456
4,4569,3515,7858,7798,5959,20711,1399,3565,1266,2333,0103,3041,6062,1623,9555,6325,1964,0583,6484,4134,7744,9605,3834,8793,5502,2261,4701,2962,4053,9264,5885,2003,0332,6842,4892,9871,6231,6711,7214,9753,4604,1034,3583,7591,5338,8448,3235926546383,8764,4994,8683,3623,5783,0113,5364,1974,0173,2542,4701,99513,86315,88416,00716,00714,35614,35615,19121,67714,26314,26314,09610,2522,5962,5961,5452,2924,7884,7882,1211,406895785349178119000001111111000
   > Total Current Liabilities 
0
0
0
1
0
0
0
1
1
1
0
0
0
0
0
119
178
260
696
806
1,317
2,032
4,788
4,788
2,292
1,545
2,596
2,596
2,787
5,091
9,732
9,732
12,857
10,723
14,356
14,356
16,007
16,007
15,884
13,863
1,995
2,470
3,254
4,017
4,197
2,880
2,792
3,358
3,362
4,868
4,499
3,876
638
654
592
809
810
1,533
1,115
1,535
1,735
1,608
3,878
1,721
1,671
1,623
2,667
2,169
2,684
3,033
4,085
3,993
3,221
2,405
1,296
1,470
2,226
3,117
2,822
2,733
2,220
1,974
2,246
1,509
1,850
2,448
4,266
2,919
2,130
1,575
3,272
2,979
3,633
4,284
4,185
3,330
3,655
2,891
2,845
2,588
2,623
3,026
3,0262,6232,5882,8452,8913,6553,3304,1854,2843,6332,9793,2721,5752,1302,9194,2662,4481,8501,5092,2461,9742,2202,7332,8223,1172,2261,4701,2962,4053,2213,9934,0853,0332,6842,1692,6671,6231,6711,7213,8781,6081,7351,5351,1151,5338108095926546383,8764,4994,8683,3623,3582,7922,8804,1974,0173,2542,4701,99513,86315,88416,00716,00714,35614,35610,72312,8579,7329,7325,0912,7872,5962,5961,5452,2924,7884,7882,0321,317806696260178119000001110001000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
133
661
1,219
2,789
2,789
425
425
410
410
510
410
4,172
4,172
4,931
1,746
740
740
3,169
3,169
3,063
1,068
927
1,529
2,410
2,809
2,447
1,645
1,774
2,407
2,424
2,952
3,731
3,088
250
250
0
0
0
0
0
0
0
0
1,800
1,800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
376
1,828
659
0
0
0
0
0
-757
0
0
477
487
499
510
522
534
53452251049948747700-757000006591,8283760000000000000000000001,8001,800000000002502503,0883,7312,9522,4242,4071,7741,6452,4472,8092,4101,5299271,0683,0633,1693,1697407401,7464,9314,1724,1724105104104104254252,7892,7891,2196611330000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
376
1,828
659
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000006591,82837600000000000000000000001,80000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
1
0
0
0
0
1
1
0
0
0
0
0
101
106
156
454
393
429
567
1,770
1,770
1,654
933
2,185
2,185
2,274
4,681
335
335
7,926
8,977
0
1,234
12,778
12,778
413
583
737
752
593
750
828
962
721
0
0
1,916
165
287
257
214
473
603
685
1,249
641
770
986
905
1,060
886
998
770
1,238
1,599
1,909
1,479
1,530
1,658
1,158
1,016
383
602
439
387
501
944
642
839
1,152
833
700
1,131
1,250
1,518
1,217
716
2,010
1,761
1,437
1,842
1,744
2,023
1,647
1,052
1,072
1,017
1,128
1,599
1,5991,1281,0171,0721,0521,6472,0231,7441,8421,4371,7612,0107161,2171,5181,2501,1317008331,1528396429445013874396023831,0161,1581,6581,5301,4791,9091,5991,2387709988861,0609059867706411,2496856034732142572871651,9160072196282875059375273758341312,77812,7781,23408,9777,9263353354,6812,2742,1852,1859331,6541,7701,770567429393454156106101000001100001000
       Other Current Liabilities 
0
0
0
0
0
0
0
0
-1
-1
0
0
0
0
0
18
72
105
242
280
227
245
229
229
213
186
0
54
2
0
5,225
5,225
0
8,977
0
12,381
0
0
12,408
12,213
331
189
250
458
922
272
296
951
939
1,316
603
500
131
331
119
206
125
285
326
440
333
355
870
311
446
648
1,147
512
725
705
717
543
738
714
561
525
583
432
464
414
373
332
465
221
478
1,018
1,353
754
563
606
981
761
1,802
1,686
1,878
1,033
1,248
1,076
1,198
1,007
922
842
8429221,0071,1981,0761,2481,0331,8781,6861,8027619816065637541,3531,0184782214653323734144644325835255617147385437177057255121,1476484463118703553334403262851252061193311315006031,31693995129627292245825018933112,21312,4080012,38108,97705,2255,22502540186213229229245227280242105721800000-1-100000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
101
106
89
89
89
89
89
0
4,559
2,079
1,358
0
2,596
7,464
9,005
4,531
4,531
8,820
4,468
0
1,975
16,007
16,007
3,477
1,651
1,664
2,281
3,003
3,559
3,275
656
220
221
2,424
3,552
3,896
3,375
507
489
473
7,514
8,034
1,249
2,643
2,823
2,367
1,852
1,096
1,410
1,225
975
320
320
1,959
2,328
1,116
595
705
1,691
735
945
1,644
433
2,057
2,650
2,741
2,800
2,167
2,139
2,208
2,748
1,366
1,036
31
31
31
31
2,599
841
5,171
7,809
5,552
5,704
5,934
3,197
6,728
1,430
1,4306,7283,1975,9345,7045,5527,8095,1718412,599313131311,0361,3662,7482,2082,1392,1672,8002,7412,6502,0574331,6449457351,6917055951,1162,3281,9593203209751,2251,4101,0961,8522,3672,8232,6431,2498,0347,5144734895073,3753,8963,5522,4242212206563,2753,5593,0032,2811,6641,6513,47716,00716,0071,97504,4688,8204,5314,5319,0057,4642,59601,3582,0794,55908989898989106101000001100000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
320
0
0
0
0
0
0
0
0
0
0
0
1,587
2,141
2,195
2,216
1,442
1,479
1,486
1,963
517
188
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000001885171,9631,4861,4791,4422,2162,1952,1411,58700000000000320000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
288
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
110
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000110000000000000000002880000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,514
8,034
0
2,643
2,824
2,367
1,852
1,096
0
0
0
320
320
0
0
1,116
595
705
0
0
0
0
433
471
508
546
584
622
660
723
785
848
848
31
31
31
31
2,599
841
5,171
7,809
0
4,836
0
0
0
0
00004,83607,8095,1718412,5993131313184884878572366062258454650847143300007055951,116003203200001,0961,8522,3672,8242,64308,0347,5140000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
900
468
564
0
0
0
0
0
0
0
0
0
110
0
0
0
0
0
0
0
0
0
0
0
0
0
0
276
0
0
0
0
0000276000000000000001100000000005644689000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
-1
0
0
0
0
-1
-1
0
0
0
0
0
-119
-144
-251
-577
0
-1,128
-2,036
-4,707
-4,707
779
-250
6,587
6,587
-1,665
-2,402
-9,586
-9,586
-19,217
-12,987
0
-11,945
-13,444
-13,444
-14,038
-12,330
-196
-920
-1,747
-2,884
-3,127
-2,517
-1,598
-1,804
-2,124
-3,974
-995
-1,354
814
1,316
757
-6,698
-3,771
2,308
4,616
1,882
-320
311
-1,468
3,301
1,955
12,500
12,567
17,996
15,028
12,186
10,365
12,182
9,291
8,018
6,858
8,138
5,707
3,058
755
766
-734
-1,789
-841
7,231
7,275
8,785
5,718
5,729
18,626
15,588
11,114
8,392
7,647
6,796
12,912
9,162
10,009
7,249
4,951
4,232
-48
12,392
12,392-484,2324,9517,24910,0099,16212,9126,7967,6478,39211,11415,58818,6265,7295,7188,7857,2757,231-841-1,789-7347667553,0585,7078,1386,8588,0189,29112,18210,36512,18615,02817,99612,56712,5001,9553,301-1,468311-3201,8824,6162,308-3,771-6,6987571,316814-1,354-995-3,974-2,124-1,804-1,598-2,517-3,127-2,884-1,747-920-196-12,330-14,038-13,444-13,444-11,9450-12,987-19,217-9,586-9,586-2,402-1,6656,5876,587-250779-4,707-4,707-2,036-1,1280-577-251-144-11900000-1-10000-1000
   Common Stock
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
2
2
2
10,225
10,451
11,044
11,991
11,991
67
66
112
112
119
119
121
121
121
160
0
180
197
197
205
238
261
262
275
275
297
334
346
350
352
353
473
513
591
627
646
657
684
734
787
808
809
827
14
17
17
21
22
24
24
24
24
26
26
27
27
30
30
30
30
36
38
38
1
3
4
5
5
6
7
7
7
7
8
9
13
13
13
13
14
14
1
10
10114141313131398777765543138383630303030272726262424242422211717148278098087877346846576466275915134733533523503463342972752752622612382051971971800160121121121119119112112666711,99111,99111,04410,45110,2252221111110000000000
   Retained Earnings Total Equity000000000000-279,611-276,162-274,645-269,836-265,713-262,423-259,471-256,806-255,272-253,794-251,107-248,366-244,891-242,003-239,857-236,673-233,818-231,208-227,779-223,817-221,402-218,035-214,568-211,641-211,145-209,474-207,589-199,760-197,655-195,736-192,985-186,6940000000-161,856-157,4390000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-57
-3
55
300
104
-2
-1
-1
-1
-880
-37
20
20
-200
-200
-21
-21
-52
-67
-83
-83
-130
-130
-147
-164
-178
-192
-199
-201
-203
-205
-207
-209
-210
-211
-211
-218
-226
-238
-252
-273
-295
-338
-410
-492
-576
-666
-759
-845
-646
-744
-853
-956
-1,039
-1,161
-1,263
-1,364
-1,465
-1,565
-1,666
-1,666
0
0
-2,036
-2,036
0
0
-2,293
-2,293
0
0
-2,449
-2,449
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000-2,449-2,44900-2,293-2,29300-2,036-2,03600-1,666-1,666-1,565-1,465-1,364-1,263-1,161-1,039-956-853-744-646-845-759-666-576-492-410-338-295-273-252-238-226-218-211-211-210-209-207-205-203-201-199-192-178-164-147-130-130-83-83-67-52-21-21-200-2002020-37-880-1-1-1-210430055-3-57000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
153,112
160,388
0
0
0
0
0
0
0
190,523
194,060
194,607
197,139
198,278
210,872
211,412
223,624
224,187
232,539
233,039
233,564
234,159
239,934
240,472
242,809
243,504
247,965
247,680
247,919
249,090
251,838
253,022
253,445
255,963
266,699
269,694
274,493
275,549
280,369
294,781
295,191
0
0
0
0
0
0
0
0
0
0
0
0
000000000000295,191294,781280,369275,549274,493269,694266,699255,963253,445253,022251,838249,090247,919247,680247,965243,504242,809240,472239,934234,159233,564233,039232,539224,187223,624211,412210,872198,278197,139194,607194,060190,5230000000160,388153,1120000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
806
0
0
0
0
806
806
815
815
815
815
815
96
465
627
2,578
671
1,858
2,588
6,119
12,238
101,124
108,710
81,880
163,760
176,442
163,721
82,648
82,628
83,038
87,420
0
128,449
131,919
131,919
133,133
138,124
140,198
140,803
141,410
142,081
143,205
146,375
149,397
150,532
152,808
153,112
160,388
162,399
166,033
167,929
169,118
170,357
176,385
184,549
190,523
194,060
194,607
197,139
198,278
210,872
211,412
223,624
224,187
232,539
233,039
233,564
234,159
239,934
240,472
241,809
243,504
247,965
247,680
247,919
249,090
251,838
253,022
253,445
255,963
266,699
269,694
274,493
275,549
280,369
294,781
295,191
295,228
297,228
298,352
298,624
305,399
305,493
305,751
306,091
307,385
307,849
308,207
318,758
318,758308,207307,849307,385306,091305,751305,493305,399298,624298,352297,228295,228295,191294,781280,369275,549274,493269,694266,699255,963253,445253,022251,838249,090247,919247,680247,965243,504241,809240,472239,934234,159233,564233,039232,539224,187223,624211,412210,872198,278197,139194,607194,060190,523184,549176,385170,357169,118167,929166,033162,399160,388153,112152,808150,532149,397146,375143,205142,081141,410140,803140,198138,124133,133131,919131,919128,449087,42083,03882,62882,648163,721176,442163,76081,880108,710101,12412,2386,1192,5881,8586712,578627465968158158158158158068060000806000



5.4. Balance Sheets

Currency in USD. All numbers in thousands.